📌 Key Takeaways
- Topic: Silica as an Anti-Caking Agent: Mechanism, Dosage and Applications
- Keywords: silica moisture absorber
- Published: 2026-11-20 01:30:50
- Field: Silica (SiO₂) raw materials · Inorganic non-metallic materials · Chemicals
Ultrafine Silica Powder: Particle Sizes, Specifications and Applications
- Hydrophobic Silica Powder: Properties, Water Repellency and Industrial Uses
- Insects cannot construct up a resistance to DE like they can a chemical pesticide
- Barium Sulfate vs Silica: Fillers for Coatings and Plastics Compared
- Targeted therapy, aiming, for instance, at antitumor treatments, can be divided into active and passive forms [ 72, 73 ]. Passive targeting is based on higher vascularity and higher vascular permeability of the tumor, as well as inflamed tissues, compared to physiological ones [ 73, 74 ]. Additionally, the lymphatic circulation of the tumor shows decreased efficiency [ 25 ], which led to easier accumulation of nanoparticles in the tumor or inflamed tissues [ 10, 27, 72, 74 ]. This passive accumulation is normally called "ELVIS" (Extravasation through Leaky Vasculature and later Inflammatory cell-mediated Sequestration) [ 72, 74 ]. From the facet of surface qualities, negatively charged nanoparticles accumulate less effectively inside cells, due to the negatively charged cell membrane, which slows down the cellular uptake, so, in this case, a neutral surface charge is more favorable [ 25 ]. In contrast, active targeting can be accomplished by functionalizing the outer surface of the silica carriers [ 10, 27, 72 ], where molecules are attached to the surface of the carriers that specifically bind to certain cell surface ligands and receptors, which are characteristic of tumor-, but not of healthy cells. This selective method provides more effective treatment and reduces the side impacts of cytotoxic APIs on healthy cells and tissues [ 10, 27 ]. The most recent findings on active targeting possibilities are summarized in Table 3. García-Fernández et al. prepared a mesoporous silica-based nanocarrier loaded with dexamethasone and capped with a particular protein to actively target the TNFR1 receptor, which is overexpressed in pro-inflammatory macrophages [ 72 ]. Since the carriers are preferably internalized by these macrophages, the cargo is released in a controlled manner, during enzymatic hydrolysis, thus preventing premature drug release, thanks to the gatekeepers. The targeting talent was tested in vitro with activated macrophages. On the other hand, the therapeutic efficiency was tested in vivo in mouse models. The researchers observed greater therapeutic impacts and fewer adverse side influences than in the case of free dexamethasone. To sum up, dexamethasone-loaded MSN has been effectively developed to actively target the lungs in acute lung injury (ALI), and this result may also be promising in other lung diseases (COPD, asthma) [ 72 ]. Teruel et al. presented a novel approach in oral inflammatory bowel sickness (IBD) therapy, using functionalized magnetic mesoporous silica microparticles [ 75 ].
- Wollastonite vs Silica: Filler Performance and Applications Compared
- How Is Silica Made? Production Methods for Each Type of Silica
Silica Gel Desiccant: How It Works, Types, Capacity and How to Choose
What is silica (SiO₂)?
spherical vs angular silica
What is the difference between fumed silica and precipitated silica?
how to disperse fumed silica 2. Effect of the Physicochemical Properties
What drives silica raw material prices?
amorphous vs crystalline silica Oral route is one of the most trustworthy and well-liked ways of drug administration, as it is one of the simplest and most convenient ways for self-medication [ 25, 56 ]. The gastrointestinal system offers an outstanding absorption surface for the introduction of the API into the systemic circulation [ 25 ]. Nevertheless, in the case of molecules with poor water solubility and poor permeability, drug formulation involves many difficulties, which can be solved by using nanocarriers [ 42, 56 ]. Ndayishimiye et al. proved that vancomycin, a high molecular weight and hydrophilic antibiotic macromolecule with poor oral bioavailability, can be effectively encapsulated using silica nanocarriers, and therefore, the necessary oral bioavailability can be made sure to eliminate the injection-related side effects [ 14 ]. The in vitro study showed a prolonged drug release from the nanocarriers compared to the pure drug form, and the in vitro permeability through Caco-2 cells revealed a significant boost in the permeation for the encapsulated drug compared to the unencapsulated form [ 14 ]. These nanocarriers may also protect pH-sensitive molecules from the acidic environment of the stomach, thereby avoiding unwanted chemical changes, and moreover, they may also protect macromolecules from enzymatic degradation [ 25, 56 ]. Based on diverse experiments, several key elements greatly influence the effectiveness of the therapy. The optimal size range was established between 50 and 200 nm [ 13 ]. Particles smaller than this are trapped in the mucus layer, and larger ones cannot pass through the tight junctions [ 13 ]. Anionic surface boosts enteral permeability [ 13, 14 ]. Overall, enteral bioavailability can be improved at several points.
/news/article.htmlDisclaimer: Prices and data are for reference only and do not constitute purchasing or investment advice. Please credit the source when republishing.